Probiotics Pilot Project
Not Applicable
- Conditions
- Staphylococcus Aureus
- Interventions
- Other: PlaceboDietary Supplement: Bacillus subtilis probiotic
- Registration Number
- NCT04247854
- Lead Sponsor
- Rothman Institute Orthopaedics
- Brief Summary
This pilot study is designed to determine if ingestion of Bacillus probiotics can cause alteration in levels of S. aureus colonization in the nose and intestine in preoperative orthopedic patients undergoing elective primary TJA.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
- Adults (age >18 years)
- Undergoing elective primary knee or hip arthroplasty
- Confirmed colonization of nares and/or rectum with S. aureus or MRSA on routine standard-of-care preadmission testing
- Written informed consent
Exclusion Criteria
- Regular use of a probiotic or prebiotic supplement within 3 months prior to enrollment
- Antibiotic use within 3 months prior to enrollment
- Active clinical infection
- Participation in other clinical trials
- Presence of pregnancy or lactation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description No intervention Placebo - Probiotic Bacillus subtilis probiotic -
- Primary Outcome Measures
Name Time Method Persistent Staphylococcus aureus colonization post-intervention: following 5 days of dietary supplementation
- Secondary Outcome Measures
Name Time Method Changes in microbiome composition post-intervention: following 5 days of dietary supplementation as determine through next generation sequencing of samples collect from the patient
Trial Locations
- Locations (1)
Rothman Institute
🇺🇸Philadelphia, Pennsylvania, United States